Whether this better functional status in TAVI patients with Hb-recovery should be ascribed to the recovery of anemia per se or rather to the fact that patients of this Hb-R subgroup are specifically those patients with the higher gradients – and, thus, have more to gain from a TAVI procedure – will remain subject of speculation. The gene discussed is GSTM1; the disease is anemia.